Nuwellis, Inc. (NUWE)
USD 0.83
(0.24%)
USD 0.83
(0.24%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 4.98 Million USD | 4.79% |
| 2022 | 4.75 Million USD | 5.88% |
| 2021 | 4.49 Million USD | 10.7% |
| 2020 | 4.05 Million USD | 42.3% |
| 2019 | 2.85 Million USD | 114.68% |
| 2018 | 1.32 Million USD | 68.1% |
| 2017 | 790 Thousand USD | 37.15% |
| 2016 | 576 Thousand USD | 316.54% |
| 2015 | -266 Thousand USD | -190.17% |
| 2014 | 295 Thousand USD | 400.0% |
| 2013 | 59 Thousand USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | -100.0% |
| 2010 | 400.02 Thousand USD | 269.36% |
| 2009 | 108.3 Thousand USD | -74.34% |
| 2008 | 422.04 Thousand USD | -84.55% |
| 2007 | 2.73 Million USD | 117.99% |
| 2006 | 1.25 Million USD | 228.25% |
| 2005 | 381.76 Thousand USD | 1529.3% |
| 2004 | 23.43 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 1.47 Million USD | 23.76% |
| 2024 Q1 | 1.19 Million USD | -14.19% |
| 2023 Q4 | 1.38 Million USD | 0.51% |
| 2023 Q3 | 1.38 Million USD | 20.4% |
| 2023 FY | 4.98 Million USD | 4.79% |
| 2023 Q1 | 1.06 Million USD | -19.83% |
| 2023 Q2 | 1.14 Million USD | 7.5% |
| 2022 Q1 | 1.1 Million USD | 23.27% |
| 2022 Q2 | 1.06 Million USD | -3.54% |
| 2022 FY | 4.75 Million USD | 5.88% |
| 2022 Q4 | 1.33 Million USD | 5.72% |
| 2022 Q3 | 1.25 Million USD | 18.44% |
| 2021 Q3 | 1.12 Million USD | -25.88% |
| 2021 FY | 4.49 Million USD | 10.7% |
| 2021 Q2 | 1.51 Million USD | 56.42% |
| 2021 Q1 | 966 Thousand USD | -15.78% |
| 2021 Q4 | 894 Thousand USD | -20.18% |
| 2020 FY | 4.05 Million USD | 42.3% |
| 2020 Q1 | 834 Thousand USD | 20.17% |
| 2020 Q2 | 1.19 Million USD | 43.76% |
| 2020 Q3 | 878 Thousand USD | -26.77% |
| 2020 Q4 | 1.14 Million USD | 30.64% |
| 2019 Q2 | 842 Thousand USD | 39.64% |
| 2019 Q1 | 603 Thousand USD | 17.09% |
| 2019 FY | 2.85 Million USD | 114.68% |
| 2019 Q4 | 694 Thousand USD | -2.53% |
| 2019 Q3 | 712 Thousand USD | -15.44% |
| 2018 Q4 | 515 Thousand USD | 14.96% |
| 2018 Q3 | 448 Thousand USD | 95.63% |
| 2018 Q2 | 229 Thousand USD | 68.38% |
| 2018 Q1 | 136 Thousand USD | 780.0% |
| 2018 FY | 1.32 Million USD | 68.1% |
| 2017 FY | 790 Thousand USD | 37.15% |
| 2017 Q4 | -20 Thousand USD | -111.43% |
| 2017 Q3 | 175 Thousand USD | -29.44% |
| 2017 Q2 | 248 Thousand USD | -35.92% |
| 2017 Q1 | 387 Thousand USD | 75.91% |
| 2016 FY | 576 Thousand USD | 316.54% |
| 2016 Q4 | 220 Thousand USD | -38.2% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q3 | 356 Thousand USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2015 FY | -266 Thousand USD | -190.17% |
| 2015 Q2 | - USD | -100.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q1 | 59 Thousand USD | -66.67% |
| 2014 Q3 | 59 Thousand USD | 0.0% |
| 2014 Q2 | - USD | -100.0% |
| 2014 FY | 295 Thousand USD | 400.0% |
| 2014 Q4 | 177 Thousand USD | 200.0% |
| 2014 Q1 | 59 Thousand USD | 0.0% |
| 2013 Q3 | 59 Thousand USD | 0.0% |
| 2013 Q4 | - USD | -100.0% |
| 2013 FY | 59 Thousand USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2011 Q4 | - USD | 100.0% |
| 2011 FY | - USD | -100.0% |
| 2011 Q3 | -50 Thousand USD | 0.0% |
| 2010 FY | 400.02 Thousand USD | 269.36% |
| 2009 FY | 108.3 Thousand USD | -74.34% |
| 2008 FY | 422.04 Thousand USD | -84.55% |
| 2007 FY | 2.73 Million USD | 117.99% |
| 2006 FY | 1.25 Million USD | 228.25% |
| 2005 FY | 381.76 Thousand USD | 1529.3% |
| 2004 FY | 23.43 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 2.55 Million USD | -95.412% |
| IceCure Medical Ltd | 1.3 Million USD | -283.308% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -991.526% |
| Acutus Medical, Inc. | -3.13 Million USD | 258.846% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Bioventus Inc. | 328.19 Million USD | 98.482% |
| BrainsWay Ltd. | 23.09 Million USD | 78.42% |
| Cerus Corporation | 86.4 Million USD | 94.233% |
| Venus Concept Inc. | 52.16 Million USD | 90.448% |
| Envoy Medical, Inc. | -473 Thousand USD | 1153.488% |
| CVRx, Inc. | 33.03 Million USD | 84.918% |
| electroCore, Inc. | 13.22 Million USD | 62.324% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -8068.852% |
| Inogen, Inc. | 126.69 Million USD | 96.067% |
| OrthoPediatrics Corp. | 111.25 Million USD | 95.521% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 182.364% |
| Spectral AI, Inc. | 7.88 Million USD | 36.764% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 10626.872% |
| MaxCyte, Inc. | 36.54 Million USD | 86.365% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 175.592% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -5758.218% |
| Orthofix Medical Inc. | 486.27 Million USD | 98.975% |
| PAVmed Inc | -3.96 Million USD | 225.58% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 190.848% |
| RxSight, Inc. | 53.76 Million USD | 90.732% |
| Sight Sciences, Inc. | 69.17 Million USD | 92.797% |
| SI-BONE, Inc. | 109.42 Million USD | 95.446% |
| TELA Bio, Inc. | 40.11 Million USD | 87.577% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 96.72% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | 39.753% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | 68.672% |
| LivaNova PLC | 771.25 Million USD | 99.354% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -573.81% |
| Talis Biomedical Corporation | 371 Thousand USD | -1243.127% |
| 908 Devices Inc. | 25.32 Million USD | 80.321% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 98.394% |
| Nemaura Medical Inc. | -1.47 Million USD | 437.512% |
| NeuroPace, Inc. | 48.12 Million USD | 89.645% |
| LENSAR, Inc. | 21.1 Million USD | 76.392% |
| Apyx Medical Corporation | 14.12 Million USD | 64.715% |
| Cutera, Inc. | 41.49 Million USD | 87.991% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | 73.008% |
| BioSig Technologies, Inc. | 18 Thousand USD | -27583.333% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 95.166% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | 63.398% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 99.439% |
| Axonics, Inc. | 274.55 Million USD | 98.185% |
| Outset Medical, Inc. | 29 Million USD | 82.817% |
| IRIDEX Corporation | 21.8 Million USD | 77.15% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 92.987% |
| IRadimed Corporation | 50.15 Million USD | 90.065% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -1636.237% |
| INVO Bioscience, Inc. | 1.08 Million USD | -358.781% |
| Telesis Bio, Inc. | 16.95 Million USD | 70.602% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 95.582% |
| Varex Imaging Corporation | 256.9 Million USD | 98.06% |
| Quipt Home Medical Corp. | 163.84 Million USD | 96.959% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 1327.34% |
| Pulmonx Corporation | 50.75 Million USD | 90.182% |
| Dynatronics Corporation | 7.63 Million USD | 34.735% |
| Modular Medical, Inc. | -768 Thousand USD | 748.828% |
| ReShape Lifesciences Inc. | 5.54 Million USD | 10.184% |
| Semler Scientific, Inc. | 61.2 Million USD | 91.858% |
| InMode Ltd. | 411.34 Million USD | 98.789% |
| Bruker Corporation | 1.51 Billion USD | 99.671% |
| Cytosorbents Corporation | 22.39 Million USD | 77.747% |
| DexCom, Inc. | 2.28 Billion USD | 99.782% |
| Align Technology, Inc. | 2.71 Billion USD | 99.817% |
| Viveve Medical, Inc. | 620 Thousand USD | -703.71% |
| ZimVie Inc. | 290.38 Million USD | 98.284% |
| Movano Inc. | -158 Thousand USD | 3253.797% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 95.446% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -5758.218% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 98.645% |
| Profound Medical Corp. | 4.51 Million USD | -10.389% |
| Insulet Corporation | 1.15 Billion USD | 99.57% |
| enVVeno Medical Corporation | -546 Thousand USD | 1012.637% |
| Surmodics, Inc. | 93.05 Million USD | 94.645% |
| iCAD, Inc. | 14.53 Million USD | 65.72% |
| Biotricity, Inc. | 8.35 Million USD | 40.368% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 98.498% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 1487.802% |
| InspireMD, Inc. | 1.8 Million USD | -175.761% |
| PAVmed Inc. | -3.96 Million USD | 225.58% |
| BIOLASE, Inc. | 16.72 Million USD | 70.204% |
| Beyond Air, Inc. | -1.3 Million USD | 481.255% |
| FONAR Corporation | 45.14 Million USD | 88.961% |
| AxoGen, Inc. | 127.87 Million USD | 96.103% |
| Vivani Medical, Inc. | -357 Thousand USD | 1495.798% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 97.446% |
| Inari Medical, Inc. | 434.56 Million USD | 98.853% |
| UFP Technologies, Inc. | 112.22 Million USD | 95.56% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -39703.499% |
| Tenon Medical, Inc. | 1.24 Million USD | -301.531% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 6251.852% |
| Co-Diagnostics, Inc. | 2.62 Million USD | -89.678% |
| AdaptHealth Corp. | 479.56 Million USD | 98.961% |
| Sintx Technologies, Inc. | 1.84 Million USD | -170.374% |
| NanoVibronix, Inc. | 1.53 Million USD | -224.203% |
| Quanterix Corporation | 70.64 Million USD | 92.947% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 1327.34% |
| Sensus Healthcare, Inc. | 14.06 Million USD | 64.559% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | 90.559% |
| TransMedics Group, Inc. | 154.09 Million USD | 96.766% |
| ReWalk Robotics Ltd. | 4.45 Million USD | -11.902% |
| NeuroMetrix, Inc. | 3.94 Million USD | -26.235% |
| Hyperfine, Inc. | 4.75 Million USD | -4.751% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 95.342% |
| Biomerica, Inc. | 611 Thousand USD | -715.548% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | 88.047% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 738.065% |
| Silk Road Medical, Inc | 127.08 Million USD | 96.079% |